Noah Ark Biotechnology — Engineering Life for Tomorrow
Pioneering Intelligent Biology

Engineering
Life's Future Through Science

Noah Ark Biotechnology merges artificial intelligence, genomics and synthetic biology to predict disease, protect biodiversity, and engineer solutions for the planet's most urgent crises.

3 Core Platforms
500+ Species in Cryobank
2026 Launch Year
Possible Impact

The Ark for
Biological Intelligence

Noah Ark Biotechnology was founded on a radical premise: the future of life on Earth depends on our ability to decode, simulate, and intelligently guide biological systems.

We operate at the intersection of genomics, AI, and synthetic biology — building the scientific infrastructure needed to respond to pandemics, reverse species extinction, and engineer microorganisms that heal the planet.

Just as Noah's Ark preserved life through catastrophe, we build systems that preserve and advance life through the crises of the 21st century.

🧬
Predictive Genomics
Early detection through epigenetic biomarkers and polygenic risk modeling
🤖
AI-Driven Biology
AlphaFold-class models for protein design and molecular simulation
🌍
Eco-Bioengineering
Organisms engineered for carbon capture, microplastic degradation and pollination
⚛️
Quantum Bio-Compute
Hybrid QPU/GPU infrastructure for molecular dynamics at scale

Core Solutions

Six breakthrough platforms transforming how humanity interacts with the living world.

01
🔬

PreviGen™ Diagnostic Kit

AI-powered early detection of polygenic diseases through DNA methylation profiling and proteomics — years before symptoms appear.

Epigenomics AI Diagnostics Precision Medicine
02
💻

Digital Twin Genomics

Virtual human models fed by real-time nanopore sequencing — simulating immune responses, drug interactions, and disease trajectories before clinical trials.

Nanopore Digital Twins Organoids
03
🦋

Project Phoenix Genome

Automated cryogenic DNA archive of 500+ threatened species, combined with synthetic biology tools for de-extinction and ecosystem restoration.

Cryogenics De-extinction Biodiversity
04
🌱

TerraBacteria Platform

Engineered microbial strains equipped with enhanced PETase enzymes for plastic degradation and bio-cement synthesis that actively sequesters atmospheric CO₂.

Synthetic Biology Climate Tech CRISPR
05
⚗️

AI Evolutionary Engine

GAN-powered directed evolution platform that designs novel enzymes, antibodies, and biomolecules optimized for therapeutic or industrial applications — in silico, at speed.

Generative AI Protein Design Drug Discovery
06
☁️

Bio-Compute Cloud

Federated hybrid computing platform integrating QPU, GPU clusters and blockchain-verified genomic data — interoperable with EMBL-EBI, All of Us and global research networks.

Quantum Cloud HPC Blockchain

Our Laboratories

SynBio Quantum Lab
Core Research Facility
Bio-FabLab Mobile
Field Deployment Unit
Phoenix Cryo Archive
Biodiversity Vault
Quantum Bio-Compute
Cloud HPC Infrastructure

SynBio
Quantum Lab

Operational

Our flagship research environment couples quantum molecular simulation with cutting-edge gene-editing hardware. The SynBio Quantum Lab is where our most ambitious experiments take form — from base editing on chip to 4D protein structure prediction validated against live organoid cultures.

Core Equipment
CRISPR-Chip — on-chip gene editing array (base-to-base resolution)
Cryo-EM with NVIDIA Clara AI-enhanced reconstruction
Oxford Nanopore PromethION — real-time long-read sequencing
Quantum Processing Unit (Pasqal) — molecular dynamics simulation
3D Organoid Culture System — automated liquid handling robotics
4D
Protein Modeling
48h
Assay Cycle Time
10⁶
Variants/Run

Bio-FabLab
Mobile

Deployable

A fully self-contained, containerized biological laboratory designed for rapid deployment in ecological crisis zones, remote field environments, or humanitarian missions. Operates off-grid with satellite data uplink to our central Bio-Compute Cloud.

Onboard Systems
Illumina iSeq 100 — portable next-generation sequencer
Bio-Rad ddPCR — digital droplet quantification
CELLINK BioX — biological tissue 3D printer
Automated biosafety cabinet (BSL-2 rated)
Satellite-linked real-time data transmission to Cloud
72h
Deployment Time
BSL-2
Safety Rated
100%
Off-Grid Capable

Phoenix
Cryo Archive

Phase I Active

The Phoenix Genome Bank is one of the most comprehensive automated cryogenic archives of threatened species DNA ever assembled. Robotic liquid handlers manage sample processing; AI cataloguing ensures 99.99% retrieval accuracy. A living backup for Earth's biodiversity.

Vault Infrastructure
−196°C liquid nitrogen cryogenic storage tanks (150,000 samples)
Hamilton robotic liquid handling platform
AI-powered sample tracking and genomic indexing
Redundant power systems with 72h emergency backup
Integration with IUCN Red List and Global Biodiversity Facility
500+
Species Archived
-196°C
Storage Temp
Viability Target

Quantum
Bio-Compute

In Development

Our distributed Bio-Compute Cloud bridges classical GPU clusters with quantum processors, enabling simulation of molecular interactions at scales previously impossible. Privacy is enforced via Zero-Knowledge Proof blockchain architecture for all genomic data.

Compute Stack
Pasqal QPU nodes — neutral atom quantum processors
NVIDIA A100 GPU cluster — deep learning inference
AWS HealthOmics — scalable genomic data pipeline
ZK-Proof blockchain — ethics-compliant genomic data sovereignty
Federated learning layer (Owkin) — privacy-preserving model training
QPU+
Hybrid Architecture
ZKP
Data Privacy
Global
API Access

From Vision
to Reality

A phased scientific roadmap — from platform validation to global commercial deployment — anchored in rigorous milestones.

2026–27
Alpha Phase — Active
Platform Validation
Digital Twin validation across 5 disease models. PreviGen prototype clinical testing. Bio-Compute Cloud v1 deployed on AWS HealthOmics.
2028–29
Beta Phase
Clinical & Commercial Trials
PreviGen Phase II clinical trials. Phoenix Genome Bank at 500 species. AI Evolutionary Engine licensed to pharma partners.
2030
Gamma Phase
Global Scale
Bio-Simulation Engine commercialized. ISO 13485 certified medical AI devices. TerraBacteria deployed in 3 continents.
🧪
CRISPR-Cas12d
Next-generation base editing for ultra-precise genomic modification
🤖
AlphaFold 3
4D protein structure prediction for drug and enzyme design
⚛️
Quantum QPU
Molecular dynamics simulation beyond classical compute limits
🔗
ZK Blockchain
Zero-knowledge proof genomic data sovereignty and traceability
🧫
Organoid AI
3D cell culture models analyzed by computer vision algorithms
🌐
Federated Learning
Privacy-preserving distributed model training across institutions
📡
Nanopore Seq
Real-time long-read sequencing with AI-enhanced base calling
🧬
Directed Evolution
GAN-accelerated in silico protein optimization pipelines

Minds Behind
the Mission

SA
Samy Aoudjane
CEO & Co-Founder

Visionary leader driving the intersection of biotechnology and artificial intelligence. Architect of Noah Ark's strategic direction, scientific partnerships, and global expansion roadmap.

SK
Sarah Kouadri
Founder — Toulouse Hub AI for Good

Pioneering advocate for responsible technology and community-centered AI. Co-founder of Toulouse Hub – AI for Good, with deep engagement in digital solidarity and ethical innovation ecosystems across Occitanie.

NK
Noah Kouadri Khazar
Project Director & Co-Founder

Researcher in quantum energy and breakthrough technologies. Student at Texas Tech University, author of Noah ArkCore and the Quantum Revolution, and Administrative Director of Toulouse Hub – AI for Good.

AK
Adam Kouadri
AI Expert & Co-Founder

ITU Young AI Leader and Hub Leader for Europe (2025–2029). Official speaker at the AI for Good Global Summit (Geneva) and representative of Toulouse Hub at Davos House AI 2026. Champion of digital solidarity and ethical AI.

The Toulouse Hub
AI for Good Founders

Three visionaries who co-founded both Noah Ark Biotechnology and Toulouse Hub – AI for Good — a globally recognised innovation centre dedicated to responsible, human-centered artificial intelligence, operating under the auspices of the ITU (United Nations) AI for Good programme.

SK
Sarah Kouadri
Founder · Toulouse Hub – AI for Good
Toulouse Hub Co-Founder Noah Ark Biotechnology AI for Good

Sarah Kouadri is a founding pillar of both Noah Ark Biotechnology and Toulouse Hub – AI for Good — a centre of innovation dedicated to ethical, human-centred artificial intelligence at the heart of Occitanie, one of Europe's most dynamic science and technology ecosystems.

As an active member and founder of the Toulouse Hub community, Sarah has been integral in shaping its mission: to connect students, researchers, NGOs and businesses to build technology that genuinely serves society. She embodies the Hub's conviction that AI must be developed responsibly — or not at all.

Sarah's commitment to digital solidarity and inclusive technology reflects her belief that the most transformative innovations are those co-designed with the communities they affect. Within Noah Ark Biotechnology, she brings this human-centred philosophy to the development of accessible, ethical biological technologies — from the PreviGen diagnostic platform to the TerraBacteria climate programme.

Her work spans the full spectrum of responsible innovation: from grassroots community engagement to international scientific collaboration — anchored always in the conviction that technology is a tool for justice, not just progress.

Organisation
Toulouse Hub – AI for Good
Location
Toulouse, Occitanie — France
Focus Areas
Digital Solidarity · Ethical AI · Community Innovation
Recognition
ITU · UN AI for Good Ecosystem · Davos 2026
Role at Noah Ark
Co-Founder · Responsible Innovation Lead
NK
Noah Kouadri Khazar
Project Director · Quantum Energy Researcher · Published Author
Texas Tech University Toulouse Hub Admin Director Published — Amazon Kindle

Noah Kouadri Khazar is a visionary in quantum energy and disruptive technologies. Currently studying at Texas Tech University as an engineering student in Sciences and Technologies of Innovation, Noah is the founder and driving force behind the concept of Noah's Ark Technology Digital Solidarity — the initiative from which Noah Ark Biotechnology draws its name and mission.

A pioneering researcher in zero-point energy, Noah developed the Noah ArkCore engine — a revolutionary quantum energy concept that seeks to harness the quantum vacuum as a clean, limitless energy source. His work merges quantum physics, astrophysics, and artificial intelligence in pursuit of energy justice: ensuring clean energy becomes universally accessible, not a privilege of the wealthy.

In 2024, Noah published "Noah ArkCore and the Quantum Revolution" on Amazon Kindle — a landmark work laying out the scientific foundations of his quantum engine concept, the social vision behind it, and the broader implications of zero-point energy for humanity's future. The book has established him as one of the youngest published researchers working at the intersection of quantum mechanics and energy justice.

As Administrative Director of Toulouse Hub – AI for Good, Noah ensures the operational coherence of the Hub's projects, coordinates partnerships with institutional actors, and maintains the strategic link between the Hub's grassroots community work and its global scientific ambitions. Within Noah Ark Biotechnology, he serves as Chief Project Director — overseeing timelines, cross-functional teams, and the translation of scientific vision into executable milestones.

Education
Texas Tech University — Engineering, Sciences & Technologies of Innovation
Research Focus
Zero-Point Energy · Quantum Mechanics · Astrophysics · AI Integration
Published Work
"Noah ArkCore and the Quantum Revolution" — Amazon Kindle, 2024
Hub Role
Administrative Director — Toulouse Hub AI for Good
Noah Ark Role
Chief Project Director & Co-Founder
AK
Adam Kouadri
AI Expert · ITU Young AI Leader · Davos 2026 Speaker
ITU — UN Young AI Leader Hub Leader — Europe 2025–2029 Davos House AI 2026 AI for Good Global Summit

Adam Kouadri is one of the most recognised young AI leaders in France and across Europe. As Founder and President of Toulouse Hub – AI for Good, he has built an internationally credentialed innovation centre from the ground up — connecting Toulouse's world-class scientific ecosystem to the global responsible AI movement.

Adam's journey began in community service. From June 2023, he volunteered with Solidarité Numérique, Éducation et Santé Castres (SNESC) — organising events, supporting digital literacy campaigns, and empowering underserved populations with practical technology access. In May 2024, he joined Noah's Ark Technology Digital Solidarity, delivering workshops and providing direct technological support to reduce the digital divide across his community.

This grassroots dedication led to international recognition. Adam was officially selected by the ITU (International Telecommunication Union — United Nations) as a Young AI Leader and Hub Leader for Europe (2025–2029) — a designation reserved for the most promising young innovators shaping the future of AI globally. He was invited as an official speaker at the AI for Good Global Summit in Geneva, the world's leading UN platform connecting AI innovators to the Sustainable Development Goals.

In January 2026, Adam represented the Toulouse Hub at Davos House AI 2026 — an official dialogue platform alongside the World Economic Forum. There, he contributed to global discussions on human-centered AI governance, digital inclusion, and the role of regional AI hubs as catalysts for responsible global innovation. His presence brought the voice of French grassroots AI to one of the world's most influential technology governance stages.

Within Noah Ark Biotechnology, Adam leads the AI research strategy — translating cutting-edge advances in machine learning, federated learning, and generative AI into deployable solutions for the PreviGen diagnostic platform, the AI Evolutionary Engine, and the Bio-Compute Cloud. His dual expertise in community AI deployment and frontier research makes him uniquely positioned at the convergence of science and social impact.

Official Title (ITU/UN)
Young AI Leader · Hub Leader Europe · 2025–2029
International Stage
Davos House AI 2026 · AI for Good Global Summit Geneva
Volunteer Work
SNESC (2023) · Noah's Ark Tech Digital Solidarity (2024)
Hub Role
Founder & President — Toulouse Hub AI for Good
Noah Ark Role
AI Expert & Co-Founder
Recognition
ITU · UN · WEF · UNESCO · EU AI Act Framework
TH
Toulouse Hub – AI for Good
Officially recognised by ITU · UN · UNESCO · Davos 2026
3UN SDGs
2026Davos Represented
ITUUN Recognition
Visit Hub Website →

Strategic
Partnerships

Broad Institute Ginkgo Bioworks EMBL-EBI Revive & Restore Twist Bioscience Owkin AI Pasqal Quantum SomaLogic AWS HealthOmics Oxford Nanopore Broad Institute Ginkgo Bioworks EMBL-EBI Revive & Restore Twist Bioscience Owkin AI Pasqal Quantum SomaLogic AWS HealthOmics Oxford Nanopore
Research
Broad Institute (MIT/Harvard)
Access to All of Us genomic database, CRISPR tool licensing, and collaborative disease modeling programs.
Industry
Ginkgo Bioworks
Co-development of bio-factory organisms for TerraBacteria and synthetic pollinators programs.
Humanitarian
Earthshot Prize
Impact funding for climate bioengineering projects with measurable carbon and biodiversity outcomes.
Technology
Pasqal + NVIDIA
Hybrid QPU-GPU compute stack powering molecular simulations and deep learning inference at scale.
Bioinformatics
EMBL-EBI
API federation with European bioinformatics infrastructure and Human Cell Atlas integration.
Conservation
Revive & Restore
De-extinction methodology, species candidacy selection, and ecological reintroduction frameworks.

Three Crises.
One Platform.

Noah Ark Biotechnology addresses humanity's most urgent biological challenges through a single, convergent scientific infrastructure.

🏥

Human Health

Polygenic diseases like Alzheimer's, breast cancer, and type 1 diabetes kill millions annually before symptoms appear. PreviGen and our Digital Twin platform shift medicine from reactive to predictive — identifying risk decades earlier, enabling prevention over treatment.

🌿

Biodiversity Loss

Earth is in its sixth mass extinction. 40,000 species vanish each year. Project Phoenix Genome creates an indestructible archive and provides the tools needed for future de-extinction — ensuring that today's losses are not permanent.

🌡️

Climate Emergency

Microplastics contaminate every ocean, every body of water, every human bloodstream. TerraBacteria deploys engineered organisms as a biological cleanup force — while simultaneously building carbon-mineralizing bio-cements that sequester CO₂ from the atmosphere.

Let's Build
Tomorrow's
Biology

Whether you're a researcher, investor, partner institution, or prospective team member — we want to hear from you.

Headquarters
Noah Ark Biotechnology
Status
● Active — Seeking Partners & Investors
Areas of Interest
Research partnerships · Institutional investment · Clinical collaboration · Licensing inquiries · Talent & careers
✓ Message received. We'll be in touch within 48 hours.
Noah Ark Biotechnology — Domains
07
Noah Ark Biotechnology

Our
Fields

Seven domains of scientific action. One mission: engineer life to serve humanity, preserve nature, and heal the planet.

Scroll
🧬
01
Domain 01

Predictive
Genomics

We decode the epigenome to predict disease before symptoms arise. By profiling DNA methylation patterns and polygenic risk scores, our PreviGen™ platform delivers a 10–20 year early warning window for major chronic illnesses.

Core Tech DNA methylation profiling · CpG site analysis
Target Diseases Alzheimer's · Cancer · Type 1 Diabetes · CVD
Prediction Window 10–20 years before clinical onset
Product PreviGen™ Diagnostic Kit
Status Alpha Validation · 2026
Active Research
⚗️
02
Domain 02

Synthetic
Biology

We design organisms that nature never built. From plastic-eating bacteria with engineered PETase enzymes to CO₂-mineralizing bio-cements, our TerraBacteria platform engineers life as infrastructure for planetary repair.

Toolkit CRISPR-Cas12d · Base editing · Kill-switches
Applications Plastic degradation · Carbon capture · Bio-cement
Platform TerraBacteria · Synthetic Pollinators
Biosafety Genetic kill-switch circuits · ISO TC/229
Partners Ginkgo Bioworks · Twist Bioscience
In Development
🤖
03
Domain 03

Biological
Artificial
Intelligence

Our AI Evolutionary Engine uses generative adversarial networks and directed evolution to design proteins, antibodies and enzymes no human researcher could conceive. We compress millions of years of evolution into days of compute.

Models AlphaFold 3 · GANs · Graph Neural Networks
Outputs Enzymes · Antibodies · Biomolecular tools
Privacy Federated Learning (Owkin) · ZK-Proof
Compute AWS HealthOmics · NVIDIA A100 cluster
Platform AI Evolutionary Engine · Bio-Compute Cloud
Core Platform
⚛️
04
Domain 04

Quantum
Biology &
Computing

We simulate molecular interactions that classical computers cannot model. Partnering with Pasqal's neutral-atom quantum processors, we unlock drug-protein binding, enzyme dynamics and quantum energy applications at unprecedented resolution.

Hardware Pasqal QPU · Neutral-atom arrays
Applications Molecular dynamics · Drug-protein binding
Integration Hybrid QPU-GPU compute stack
Research Link Noah ArkCore Quantum Energy concept
Timeline Bio-Compute Cloud Phase II · 2028
Emerging Domain
🌱
05
Domain 05

Climate
Bioengineering

Biology is the most powerful engineering platform on Earth. We deploy it against the climate crisis: bacteria that eat microplastics, organisms that build carbon-storing structures, and synthetic pollinators that restore collapsing ecosystems.

Solutions PETase v3 · Bio-cement · Synthetic pollinators
UN SDGs SDG 13 Climate · SDG 14 Oceans · SDG 15 Land
Scale Target 3 continental deployments by 2029
Partners Earthshot Prize · Biomason · EPA framework
Platform TerraBacteria · Bio-FabLab Mobile
Field Deployment
🦋
06
Domain 06

Biodiversity
& De-
Extinction

Earth loses 40,000 species per year. We build the systems to ensure no extinction is permanent. The Phoenix Genome Bank is our answer: an automated, cryogenic genetic archive and the R&D engine to eventually restore what was lost.

Archive 500+ species · −196°C cryogenic storage
Tools CRISPR reconstruction · Genomic indexing AI
Partners Revive & Restore · IUCN Red List · GBIF
2030 Target 5,000 species archived and indexed
Platform Phoenix Genome Bank · Cryo Archive Lab
Phase I Active
💻
07
Domain 07

Digital Twin
Medicine

A living computational replica of a patient — built from real-time nanopore sequencing and 3D organoid models, recalibrated continuously by AI. Test drugs, simulate immune responses, predict disease trajectories. Before touching a single patient.

Data Layer Oxford Nanopore · Organoid cultures · EHR
AI Layer AlphaFold 3 · LSTM · Transformer models
Validation 5 disease models · 10,000+ patient datasets
Partners EMBL-EBI · Tempus Labs · Owkin
Phase Alpha Validation · 2026–2027
Active Validation

7 Domains.
1 Future.

Every domain is a vector of impact. Together, they form a unified scientific infrastructure for the challenges of the 21st century.

Contact the Team
Noah Ark Biotech — Domains © 2026 Noah Ark Biotechnology · noaharktechnology@gmail.com
Noah Ark Biotechnology — Labs · Collaborations · Patents
Laboratories

Four specialised research environments forming an integrated experimental ecosystem — from quantum molecular simulation to field-deployed ecological intervention.

4 Facilities · 2 Continents
BSL-1 → BSL-2 Certified

Our flagship wet-lab and computational hub — where quantum molecular simulation meets live CRISPR editing on chip. The SynBio Quantum Lab is the birthplace of PreviGen™, TerraBacteria, and our AI Evolutionary Engine validation pipeline. It integrates the most advanced gene-editing hardware with AI-enhanced imaging and real-time nanopore sequencing.

Sample Prep
Nanopore Seq
AI Analysis
CRISPR Edit
Organoid Validation
QPU Simulation
Primary Function
Genomic editing, protein design, organoid culture, AI model validation
Sequencing
Oxford Nanopore PromethION
Gene Editing
CRISPR-Chip · CRISPR-Cas12d · Base editing (BE4max)
Imaging
Cryo-EM + NVIDIA Clara AI reconstruction pipeline
Compute Node
Pasqal QPU + NVIDIA A100 GPU cluster
Cell Systems
3D organoid culture · Hamilton robotic liquid handling
Throughput
10⁶ variants / run · 48h assay cycle
Biosafety Level
BSL-2 · ISO 15189 accredited
CRISPRNanoporeQuantum ComputeOrganoidsCryo-EMAlphaFold 3
NAB_SQ_LAB > status --all [ OK ] Nanopore PromethION → READY (flow cell: 96h remaining) [ OK ] CRISPR-Chip array → LOADED (guide RNA batch #47) [ OK ] QPU node → ONLINE (coherence: 98.4%) [ RUN ] AlzPredict model → TRAINING (epoch 142/500) [ OK ] Organoid Array A3 → VIABLE (day 12 culture)

→ Request Lab Access

A fully self-contained, BSL-2-rated biological laboratory engineered inside a standard ISO shipping container. Deployable within 72 hours to remote ecological crisis zones, outbreak sites, or humanitarian intervention areas. Operates entirely off-grid with satellite uplink to our central Bio-Compute Cloud — bringing cutting-edge DNA analysis to the field.

Deploy 72h
Field Sampling
iSeq Sequencing
Edge AI Analysis
Satellite Upload
Cloud Report
Format
ISO 20ft container · Climate-controlled · HVAC
Sequencer
Illumina iSeq 100 · Oxford Nanopore MinION
Quantification
Bio-Rad QX200 ddPCR · Qubit fluorometer
Bioprinting
CELLINK BioX (tissue scaffold printing)
Power
Solar + LFP battery · 96h autonomous operation
Connectivity
Starlink terminal · Encrypted VPN to Cloud
Biosafety
BSL-2 · Negative pressure cabinet · HEPA
Deployment Time
72 hours from logistics trigger
Off-GridBSL-2Satellite LinkddPCRField Sequencing
FABLAB_MOBILE > deploy --location=field --mode=autonomous [ OK ] Solar array → 94% charge · Runtime: 96h [ OK ] Starlink uplink → 182 Mbps ↑ · latency 38ms [ OK ] BSL-2 cabinet → Negative pressure confirmed [ OK ] iSeq 100 → Cartridge loaded · Ready [ STANDBY ] Awaiting field coordinates upload

→ Request Deployment

The Phoenix Genome Bank is one of the most comprehensive automated cryogenic genetic archives ever built for biodiversity conservation. Operating at −196°C using liquid nitrogen immersion, it preserves viable DNA, gametes, tissue and cellular material from threatened and critically endangered species. Robotic handling ensures contamination-free intake; AI cataloguing provides 99.99% retrieval accuracy.

Species ID
Sample Collection
DNA Extraction
Quality Check
Cryo-Vitrification
Archive + Index
Storage Temp
−196°C · Liquid Nitrogen Immersion
Capacity
150,000 samples · Phase I: 500 species
Handling
Hamilton STAR robotic liquid handler
Cataloguing
AI genomic indexing · 99.99% retrieval accuracy
Sample Types
gDNA · Gametes · Tissue · Stem cells · Spores
Redundancy
3× power backup · 72h emergency LN₂ reserve
2030 Target
5,000 species · Global distribution network
Integration
IUCN Red List · GBIF · Revive & Restore
Cryogenics500+ SpeciesRobotic HandlingDNA ArchivalDe-Extinction

→ Submit a Species

The Quantum Bio-Compute Hub is the digital backbone of Noah Ark Biotechnology — a federated hybrid platform bridging quantum processors, GPU clusters, and privacy-preserving AI infrastructure. It enables molecular simulations, AI model training, and global data federation that no single classical computer farm can achieve. Genomic data sovereignty is guaranteed via Zero-Knowledge Proof blockchain architecture.

Data Ingestion
ZKP Encryption
Federated Training
QPU Simulation
GPU Inference
API Output
Quantum Layer
Pasqal neutral-atom QPU · 200+ qubit array
Classical Layer
NVIDIA A100 ×8 cluster · AWS HealthOmics
Privacy Layer
Zero-Knowledge Proof · Federated Learning (Owkin)
Data Federation
EMBL-EBI · All of Us (NIH) · Human Cell Atlas
Blockchain
Genomic data traceability · GDPR-compliant
API Access
Open academic · Commercial licensing available
Applications
Drug-protein binding · Enzyme dynamics · Digital Twins
Launch
Phase I — Q3 2026 · Full deployment 2028
QPUFederated LearningZK BlockchainAWS HealthOmicsOpen API

→ Request API Access
Collaborations

A global network of scientific, institutional and industry partners co-building the future of biological intelligence — from research universities to quantum computing firms.

12 Active Partnerships
4 Continents · 8 Countries

The Broad Institute is our primary academic research partner for large-scale genomics and CRISPR development. This collaboration provides access to the NIH's All of Us genomic database — over 1 million participant genomes — for PreviGen™ validation, as well as licensing of next-generation CRISPR base-editing tools.

Partnership Type
Joint Research Agreement · Data Access License
Key Deliverable
Access to All of Us 1M+ genome cohort
Technology
CRISPR base editing · Genome-wide association
Duration
2026 → 2030 · Renewable
2025
MOU signed — joint genomic research framework established
2026
PreviGen™ validation begins on Broad cohort datasets
2027
Co-publication target — epigenetic biomarker panel for Alzheimer's

GenomicsCRISPRAll of Us

Our European bioinformatics backbone. EMBL-EBI provides API federation with global biological databases — UniProt, Ensembl, and the Human Cell Atlas — enabling our Digital Twin platform to draw from the world's most comprehensive proteomics and transcriptomics reference sets. Critical for our Digital Twin validation against 10,000+ retrospective patient datasets.

Databases
UniProt · Ensembl · Human Cell Atlas · ArrayExpress
Integration
Federated API · Real-time data pipelines
Use Case
Digital Twin retrospective validation
Data Volume
10,000+ anonymised patient datasets
BioinformaticsAPI FederationProteomicsHuman Cell Atlas

Ginkgo Bioworks operates the world's largest cell programming infrastructure. Our collaboration leverages their automated foundry for the development and scale-up of TerraBacteria organisms and synthetic pollinators. Ginkgo's high-throughput strain design platform accelerates our in-house directed evolution cycles from months to days.

Focus
TerraBacteria · Synthetic Pollinator strains
Ginkgo Asset
Automated organism foundry · 200+ automated lines
Our Contribution
AI Evolutionary Engine designs · Target specs
IP Split
Shared IP — Noah Ark holds climate deployment rights
Synthetic BiologyScale-UpClimateAutomation

Pasqal builds neutral-atom quantum processors capable of simulating molecular interactions at scales that surpass classical hardware. Our collaboration integrates Pasqal QPU nodes directly into the Bio-Compute Cloud for drug-protein binding simulations, enzyme reaction modelling and quantum-enhanced protein folding predictions. A cornerstone of the quantum biology domain.

QPU Type
Neutral-atom · 200+ qubit · Analog + Digital modes
Applications
Molecular dynamics · Drug binding · Enzyme catalysis
Integration
Hybrid QPU-GPU pipeline · AWS HealthOmics bridge
Location
Cloud-accessed · Paris HQ + remote node access
QuantumMolecular DynamicsQPUFrance

Owkin pioneered federated learning for medical AI — training models on patient data across institutions without the data ever leaving the hospital. This is the privacy architecture underlying our Bio-Compute Cloud and PreviGen™ model training. Owkin's framework ensures GDPR compliance and enables cross-continental AI training without genomic data sovereignty risks.

Technology
Federated Learning · Differential Privacy
Use Case
PreviGen model training across hospital cohorts
Compliance
GDPR · HIPAA · EU AI Act Risk Framework
Scale
50+ hospital network available for training
Federated LearningPrivacy AIGDPR

Revive & Restore is the world's leading wildlife conservation organisation specialising in genomic technologies for de-extinction. Together, we are developing the methodological framework for eventual species revival using Phoenix Genome Bank material — defining viability criteria, ecological suitability scoring, and reintroduction protocols for CRISPR-reconstructed genomes.

Focus
De-extinction methodology · Species selection criteria
Shared Work
Genomic reconstruction protocol · Eco-suitability scoring
Target Species
Woolly Mammoth proxies · Passenger Pigeon · Thylacine
Timeline
First reconstruction attempt target: 2029
De-ExtinctionCRISPRConservationEcology

Oxford Nanopore's PromethION platform is central to our real-time sequencing pipeline in the SynBio Quantum Lab, and their MinION devices power our Bio-FabLab Mobile field operations. Their nanopore technology enables direct, label-free DNA and RNA sequencing at single-molecule resolution — the data feed for our Digital Twin platform's continuous recalibration engine.

Devices
PromethION (lab) · MinION (field) · Flongle (rapid)
Read Length
Ultra-long reads >4 Mb · Structural variant detection
Integration
Direct AI base-calling · Digital Twin data feed
Application
Epigenome profiling · Direct methylation detection
Nanopore SeqLong ReadsEpigenomicsReal-Time

Twist Bioscience manufactures high-fidelity synthetic DNA on silicon at a scale and accuracy no other platform matches. They are the synthesis arm of our AI Evolutionary Engine — translating AI-designed protein sequences into physical oligo pools and gene constructs within 48 hours. This closes the in silico → wet lab loop at unprecedented speed.

Technology
Silicon-based DNA synthesis · 99.99% fidelity
Throughput
10,000+ unique sequences per order cycle
Turnaround
48h synthesis-to-delivery for priority orders
Integration
AI Evo Engine → Twist API → SynBio Lab
DNA SynthesisOligo PoolsHigh-Throughput

Toulouse Hub – AI for Good is the ethical and responsible AI cornerstone of the Noah Ark ecosystem. Co-founded by Adam Kouadri, Noah Kouadri Khazar and Sarah Kouadri, it provides the ethical review framework, federated learning governance, and community AI deployment expertise that underpins every Noah Ark AI system. Officially recognised by the ITU (United Nations) and represented at Davos 2026.

Recognition
ITU · UNESCO · Davos House AI 2026
Role
Ethics review · AI governance · Community deployment
Founders
Adam Kouadri · Noah Kouadri Khazar · Sarah Kouadri
Scope
Europe Hub Leader · 2025–2029 mandate
AI EthicsITU · UNDavos 2026France

SomaLogic's SomaScan platform measures 7,000+ proteins simultaneously from a single blood sample — the most comprehensive proteomics panel in clinical use. This multi-omic data layer complements our epigenomic biomarker profiles in PreviGen™, creating a combined genomic + proteomic early-warning signal with substantially higher predictive accuracy than either alone.

Platform
SomaScan · 7,000+ protein analytes
Sample Type
Plasma · 55µL per assay
Integration
PreviGen™ multi-omic score computation
Value Add
+34% predictive accuracy over DNA-only baseline
ProteomicsMulti-OmicsPreviGen

The Earthshot Prize is the world's most prestigious environmental award — rewarding and accelerating solutions to the planet's greatest environmental challenges. Noah Ark is pursuing Earthshot candidacy for the TerraBacteria Climate Platform and Phoenix Biodiversity Programme. The Prize's network provides not only funding but global deployment infrastructure and regulatory facilitation across 50+ countries.

Prize Category
Revive Our Oceans · Protect & Restore Nature
Projects
TerraBacteria · Phoenix Genome Bank
Prize Value
£1M per winner · Global deployment support
Status
Application preparation · 2026 cycle
ClimateImpact FundingConservation

AWS HealthOmics is the cloud backbone of Noah Ark's Bio-Compute infrastructure — providing petabyte-scale genomic data storage, variant calling pipelines, and HIPAA-compliant data exchange. It serves as the classical compute layer beneath our Pasqal QPU integration, enabling seamless orchestration of hybrid quantum-classical workflows at clinical data scale.

Capabilities
Petabyte genomic storage · Variant calling pipelines
Compliance
HIPAA · SOC 2 · ISO 27001 · GDPR
Integration
Pasqal QPU bridge · Owkin FL layer · EMBL-EBI API
Throughput
WGS pipeline: 30× coverage in <4 hours
Cloud HPCHIPAAGenomics ScaleAWS
Patents — DNA Biology

Our intellectual property portfolio spanning epigenomics, synthetic biology, AI-assisted molecular design, and cryogenic preservation — filed under PCT and US/EU patent frameworks.

18 Applications Filed
PCT · US · EU · FR Jurisdictions

A diagnostic method employing a novel multi-locus CpG methylation signature panel — identified via machine learning analysis of 1M+ genome cohort — for predicting onset risk of Alzheimer's disease, breast cancer, and type 1 diabetes 10–20 years before clinical manifestation.

Filing Date
March 2026 · PCT International
Jurisdictions
PCT → US · EU · JP · CA
Field
Epigenomics · Clinical Diagnostics · AI
Linked Product
PreviGen™ Diagnostic Kit
Key Claims
C.1A method for predicting polygenic disease risk comprising analysis of a ≥47-locus CpG methylation signature using a trained transformer-based classifier
C.2The biomarker panel of claim 1, wherein methylation data is obtained via direct nanopore sequencing without bisulfite conversion
C.3Integration with proteomics layer (≥500 analytes) to produce a composite polygenic risk score with AUC >0.91
PCTEpigenomicsAI DiagnosticsCpG Methylation

A computational platform for designing novel protein sequences using generative adversarial networks trained on evolutionary fitness landscapes — producing enzymes, antibodies, and functional biomolecules with user-defined activity profiles. Validated against 3,000+ experimentally characterised protein variants.

Filing Date
February 2026 · PCT International
Field
Computational Biology · ML · Synthetic Biology
Key Innovation
GAN + fitness landscape → novel enzyme design in <48h
Linked Product
AI Evolutionary Engine
Key Claims
C.1A computer-implemented method for protein sequence generation using conditional GANs trained on multi-species fitness landscape embeddings
C.2The system of claim 1, wherein generated sequences are validated in silico via AlphaFold structure prediction and molecular dynamics scoring before synthesis
C.3Application to thermostable PETase enzyme variants with ≥40× ambient-temperature activity improvement over wild-type
PCTProtein DesignGANDirected Evolution

Novel engineered PETase enzyme variants (FAST-PETase v3 series) exhibiting 40× greater catalytic activity at ambient water temperatures (15–25°C) compared to wild-type, enabling practical ocean and freshwater microplastic degradation without energy input. Produced via our AI Evolutionary Engine and validated in controlled marine microcosm studies.

Filing Date
January 2026 · USPTO Provisional
Enzyme Type
PETase · MHETase · FAST-PETase v3 family
Activity
40× WT · Tm +28°C · pH 6–9 active range
Target
PET · PBS · PBAT microplastics in marine environments
Key Claims
C.1Isolated PETase polypeptide comprising mutations at positions S238F, W159H, and A180I with ≥40× improved kcat/Km at 25°C versus wild-type
C.2Microbial host cell expressing the PETase variant of claim 1, optionally co-expressing MHETase for complete PET depolymerisation
C.3Method for bioremediation of microplastic-contaminated aquatic environments using a consortium of claim 2 organisms with embedded kill-switch genetic circuit
USPTOPETaseBioremediationTerraBacteria

A system and method for constructing and maintaining a continuously-updated patient-specific biological digital twin — integrating real-time long-read nanopore sequencing data, 3D organoid experimental validation, and AI-based state-space modelling for simulating physiological responses to therapeutic interventions before clinical administration.

Filing
EPO Application · March 2026
System Components
Nanopore data feed · Organoid validation · LSTM model
Clinical Use
Drug response simulation · Immune trajectory modelling
Linked Product
Digital Twin Genomics Platform
Key Claims
C.1A computational system comprising: (a) a real-time nanopore sequencing interface; (b) a patient-state model updated at ≤24h intervals; (c) a drug-response simulation module using validated organoid readouts
C.2The system of claim 1, wherein the patient-state model employs a transformer architecture trained on federated multi-institutional EHR datasets
C.3Method for predicting therapeutic response comprising generating ≥1,000 in silico simulations per drug candidate prior to clinical trial enrolment
EPODigital TwinNanoporeClinical AI

A fully automated, AI-indexed cryogenic biological archive system designed for long-term storage of multi-species genetic material. Combines robotic liquid handling, barcode-tracked cryo-vials at −196°C, and a machine learning catalogue system enabling retrieval of specific genomic material with 99.99% accuracy from archives of 150,000+ samples.

Filing
INPI France · January 2026 → PCT extension pending
System
Robotic handling · LN₂ immersion · AI indexing
Capacity
150,000+ samples · Multi-species · Multi-type
Retrieval
99.99% accuracy · <4 min sample-to-bench time
Key Claims
C.1An automated cryogenic archive comprising: robotically-managed cryo-storage at −196°C; 2D barcode tracking; and an AI classification system linking sample IDs to genomic sequence databases
C.2The system of claim 1, wherein the AI indexing module cross-references IUCN conservation status and GBIF taxonomic data for automated priority-flagging
C.3Method for biological material retrieval achieving ≥99.99% accuracy via multi-layer barcode + genomic hash verification
INPI FranceCryogenicsBiodiversityAI Indexing

A cryptographic framework applying Zero-Knowledge Proof (ZKP) protocols to genomic data federation — enabling AI models to be trained, validated and audited across institutional genomic databases without any raw sequence data leaving the originating institution. Solves the fundamental tension between AI data hunger and genomic privacy rights.

Filing
PCT International · February 2026
Cryptography
ZK-SNARKs · Differential Privacy · Secure MPC
Compliance
GDPR Art.9 · HIPAA · EU AI Act · UNESCO Ethics
Application
Bio-Compute Cloud · PreviGen federated training
Key Claims
C.1A federated genomic AI system wherein model gradient updates are verified via ZK-SNARK proofs before aggregation, without exposing underlying sequence data
C.2The system of claim 1 further comprising an on-chain audit trail recording model training provenance without storing genomic content
C.3Method for genomic data sovereignty enforcement enabling ≥50 institutional participants to jointly train a diagnostic AI with mathematical privacy guarantees
PCTZK ProofsBlockchainPrivacy AI
Patent Portfolio Notice

These filings represent a selection of 18 total applications currently under prosecution. Additional patents covering CRISPR delivery vectors, synthetic pollinator genotypes, bio-cement bacterial consortia, and quantum enzyme simulation methods are pending publication under the 18-month PCT confidentiality window. All patent rights are held by Noah Ark Biotechnology. Licensing inquiries: noaharktechnology@gmail.com

// Get involved
Partner.
Collaborate.
Innovate.
Noah Ark Biotech · Labs & Patents · 2026 noaharktechnology@gmail.com · All IP rights reserved

NOAH KOUADRI


⭐⭐⭐⭐⭐


SARAH KOUADRI


⭐⭐⭐⭐⭐


Contact Us

Call 1-987-654-3210